CBOE Global Markets Boston Consulting Group Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Prioritize Cboe's Portfolio with the BCG Matrix
Cboe Global Markets' BCG Matrix preview maps core businesses-options exchanges, market data and analytics, clearing, and multi-asset volatility and FX products-onto market growth and relative share to identify early Stars, Cash Cows and strategic trade – offs as trading dynamics shift. The full BCG Matrix provides quadrant-level placements, prioritized strategic options and capital-allocation guidance to focus resource allocation, investment decisions and product planning. Purchase the complete report for a ready-to-use Word analysis and an Excel summary that accelerates decision-making.
Stars
Index Options Suite (SPX and VIX)
The proprietary index options suite, led by S&P 500 Index (SPX) and Cboe Volatility Index (VIX) options, is a Star in CBOE Global Markets' BCG matrix, with SPX averaging 3.9 million contracts daily and VIX hitting a record 862,000 daily in 2025.
These volumes gave Cboe a dominant share of global listed derivatives flows in 2025, driving fee growth and high-margin trading revenue.
The products enjoy near-monopoly status for institutional volatility hedging, but sustaining leadership needs ongoing tech spend and expanded global distribution.
Short-Dated 0DTE Options
Zero-days-to-expiry (0DTE) options became a high-growth Stars segment, hitting 59% of total SPX volume by end-2025 with average daily SPX 0DTE volume at 2.3 million contracts.
Cboe, as market leader, must defend share aggressively and invest in latency, clearing capacity, and risk infrastructure to handle multi-million contract daily spikes.
Cboe Data Vantage
Data Vantage is a Star: high-growth, high-margin market data and analytics within CBOE Global Markets, posting 9-12% revenue growth in 2025 and contributing roughly $220-260M to group subscription revenues.
It holds a leading share in proprietary exchange data niches, driven by unit sales plus new offerings-nanosecond time-stamping and dedicated cores-boosting ARR and increasing average contract value by ~18% in 2025.
Because market data is critical for algorithmic trading, Data Vantage's expanding user base and high retention forecast a transition from Star to a large Cash Cow as customers mature and margins stabilize above 60%.
European Cash Equities
Cboe Europe Equities hit a record 25% market share in 2025, with average daily notional volume of €12.8 billion, marking high growth and clear market leadership in a fragmented European cash equities market.
The segment's strength rests on innovative venues like Periodic Auctions and BIDS Europe and requires continued investment in pan – European clearing and trading tech to defend share versus national exchanges and MTFs.
- 2025 market share 25%
- Avg daily notional €12.8bn
- Key products: Periodic Auctions, BIDS Europe
- Need: pan – EU clearing & trading upgrades
Global FX Spot Trading
Global FX Spot Trading: Cboe reported record spot average daily notional volumes of $49.7 billion in 2025, reflecting strong share gains in a competitive global FX market.
The business leads in electronic FX spot, benefiting from a secular shift to transparent, exchange-style currency trading and growing client adoption.
It generates substantial cash flow but needs ongoing capital expenditure to expand global liquidity pools and tech infrastructure to sustain high growth.
- 2025 ADNV $49.7B
- Leading electronic FX spot market position
- High cash generation; ongoing capex required
- Focus: liquidity expansion, global tech footprint
Cboe 2025: SPX 3.9M/day, VIX 862k, Data Vantage $240M ARR, EU Equities 25%
Stars: proprietary index options (SPX avg 3.9M/day; VIX peak 862k/day 2025), 0DTE 59% of SPX (2.3M/day); Data Vantage rev growth 9-12% (2025) ~$240M ARR; Cboe Europe equities 25% share, €12.8B ADNV; FX spot ADNV $49.7B (2025).
| Product | 2025 Metric |
|---|---|
| SPX | 3.9M/day |
| VIX | 862k/day |
| 0DTE | 59% (2.3M/day) |
| Data Vantage | $240M ARR |
| EU Equities | 25% / €12.8B |
| FX Spot | $49.7B |
What is included in the product
Detailed Word Document
Comprehensive BCG Matrix analysis of CBOE Global Markets' units with strategic advice on Stars, Cash Cows, Question Marks, and Dogs.
Customizable Excel Spreadsheet
One-page CBOE Global Markets BCG Matrix placing each business unit in a quadrant for quick strategic clarity
Cash Cows
Multi-Listed Options
Multi-listed options are a Cash Cow: mature, high-share contracts that generated steady transaction and clearing fees to fund growth; in 2025 they traded 3.4 billion contracts, securing Cboe Global Markets' dominant U.S. position despite steep price competition.
Because the market is stable, Cboe should focus on operational efficiency and infrastructure stability-latency cuts and margin optimizations-to maximize free cash flow rather than heavy new-product marketing.
U.S. Equities On-Exchange
The U.S. Equities on-exchange business is a classic Cash Cow in a mature market dominated by NYSE and Nasdaq, with Cboe's share at about 9.4%-10.5% in 2025 and average daily ADV (average daily volume) ~1.1 billion shares supporting steady order flow revenue.
It generates high-margin revenue from transaction fees and access charges-Cboe reported equities trading revenue of $530 million in FY 2024, running-rate margins above 60% in 2025.
Minimal capex is needed to sustain matching engines and connectivity, so free cash flow is redirected to growth initiatives like digital assets and 0DTE products, which received targeted R&D and M&A funding in 2024-2025.
Access and Capacity Fees
Access and capacity fees generate recurring, high-margin cash for Cboe: in 2024 connectivity and colocation fees contributed roughly $220m, about 12% of total non-trading revenue, reflecting captive demand for access to Cboe's unique liquidity and proprietary products.
Cboe Clear Europe
Cboe Clear Europe is a leading pan-European clearing house with a stable, high market share in the mature European clearing landscape, acting as a utility-like central counterparty supporting multiple trading venues.
In 2025 net settlement volumes rose 22%, reflecting resilience and operational efficiency; the unit delivers steady cash flow, low marketing needs, and helps fund CBOE Global Markets' strategic realignment and dividend policy.
- 2025 net settlement +22%
- Mature, high market share across European venues
- Reliable cash flow; low marketing spend
- Supports CBOE dividends and strategic shift
U.S. Equities Off-Exchange (BIDS Trading)
The off-exchange segment, powered by BIDS Trading, is a mature leader in block trading and dark pools, reporting a record ADV of 155 million matched shares in 2025 and holding ~17% market share.
It is a go-to venue for institutions executing large orders with low market impact, supplying stable, diversified revenue that offsets CBOE Global Markets' more volatile on-exchange fees.
- 2025 ADV: 155 million matched shares
- Approx. market share: 17%
- Primary users: institutional block trades, dark liquidity
- Revenue role: stable, diversified vs on-exchange fees
High – Margin Cash Cows: Options, U.S. Equities, Clear Europe & BIDS Fuel Growth
Cash Cows: multi-listed options (3.4B contracts, 2025), U.S. on-exchange equities (9.4-10.5% share; ~1.1B ADV), Cboe Clear Europe (net settlement +22% in 2025), BIDS off-exchange (155M ADV; ~17% share); these units drive high-margin recurring fees (~$530M equities rev 2024; ~$220M connectivity 2024) and fund growth/dividends.
| Unit | 2025 Key | Revenue/Note |
|---|---|---|
| Options | 3.4B contracts | Dominant U.S. fees |
| U.S. Equities | 9.4-10.5% share; ~1.1B ADV | $530M rev (FY24) |
| Clear Europe | Net settlement +22% | Utility-like cash flow |
| BIDS | 155M ADV; ~17% share | Stable block-trade revenue |
What You're Viewing Is Included
CBOE Global Markets BCG Matrix
The file you're previewing is the exact CBOE Global Markets BCG Matrix report you'll receive after purchase-no watermarks, no placeholders-fully formatted and analysis-ready for strategic planning or presentations.
Dogs
Japanese Equities Business
The Japanese equities business was a Dogs quadrant asset: low growth and low market share, unable to scale versus local incumbents like Japan Exchange Group; it generated negative free cash flow, consuming about $8-12m annually by mid-2025.
Cboe Global Markets began a wind-down in late 2025 as part of a strategic exit of underperforming international franchises, citing no clear path to market leadership or meaningful profitability.
U.S. and European Corporate Listings
Despite attempts to rival NYSE and Nasdaq, Cboe's U.S. and European corporate listings unit was a Dog: single-digit market share in a sector with ~1% annual listing growth and >70% concentration among the top two exchanges as of 2024.
Cboe formally ended listings operations in 2025 to stop capital and management drain after posting successive annual segment losses and low fee capture versus peers.
Exiting lets Cboe redeploy staff and $30-50m annualized spend toward derivatives and market-data businesses, where 2024 adjusted EBITDA margins exceeded 50%.
Cboe Europe Derivatives Platform
Launched with high hopes, the Cboe Europe Derivatives platform failed to dent market share versus Eurex and Euronext, capturing under 3% of European equity derivatives volume by 2024 and below 1% of open interest by mid-2025.
By year-end 2025 CBOE Global Markets announced winding down the platform, citing persistent low liquidity and cumulative operating losses estimated at ~€45m since launch.
The move matches a classic BCG Matrix divestiture: eliminate a Dog-low market share, low growth-freeing capital for higher-return Stars and Question Marks.
Small-Scale Risk and Market Analytics Units
Various smaller analytics and risk-management units acquired earlier were classified as Dogs for having low market share and limited growth in the crowded SaaS market; by 2024 they contributed under 3% of Cboe Global Markets' revenue (about $60m of $2.1b).
In 2025 Cboe began cost cuts and rationalization, targeting ~20-30% headcount and 40% opex reductions across these units, moving away from niche software that poorly integrated with core exchange operations.
Management labeled them non-core and set divestiture or phase-out plans, aiming to reallocate capital to higher-margin listing and market-data services that drove 70%+ of adjusted operating income in 2024.
- Dogs: <3% revenue, ~$60m of $2.1b (2024)
- 2025 cuts: 20-30% headcount, 40% opex trimmed
- Strategy: divest or phase out non-core SaaS units
- Focus shift: reinvest in listings and market data (70%+ operating income)
Legacy Futures Products (Non-Proprietary)
Legacy, non-proprietary futures on Cboe have exhibited stagnant volume-down about 12% YoY in 2024 with many contracts trading under 50 contracts/day-while proprietary products like the VIX futures grew 8% and account for the bulk of fee revenue.
These legacy listings largely break even but tie up matching engine capacity and support staff; Cboe reduced ~18 such low-liquidity futures in 2024 to focus on higher-growth index products.
- Legacy futures: volumes down ~12% YoY (2024)
- Many contracts <50 trades/day; break-even economics
- Cboe removed ~18 low-liquidity listings in 2024
- VIX futures grew ~8% and drive majority fee income
CBOE axes low – return units to redeploy $30-50M into high – margin derivatives
CBOE's Dogs (low share, low growth) included Japanese equities, non-core SaaS, European listings and legacy futures; together they generated ~3% of 2024 revenue (~$60m of $2.1b), consumed ~$8-12m (Japan) and ~€45m cumulative losses (Europe), and prompted 2025 cuts (20-30% headcount, 40% opex) to redeploy $30-50m annually into high-margin derivatives and market-data.
| Unit | 2024 rev | Share | Losses/impact |
|---|---|---|---|
| Non-core SaaS | $60m | <3% | Divest/phase-out |
| Japan equities | - | Low | $8-12m/yr cash burn |
| Europe listings | - | Low | €45m cum. loss |
| Legacy futures | - | Stagnant | Volumes -12% YoY |
Question Marks
Event and Prediction Markets
Cboe will launch its first regulated event and prediction markets in 2026, entering a fast-growing segment estimated at $1.5-2.0 billion gross market volume in 2025 for political/economic betting platforms.
Market share is near zero for Cboe now; decentralized rivals (e.g., Augur, Polymarket) claim ~60-70% of on – chain volume, so Cboe's regulated model may struggle to convert that traffic.
This is a BCG Question Mark: Cboe must invest heavily in 2025-2026 (platform build, liquidity incentives, compliance) to reach scale; a target break – even would likely need 30-50% year – over – year volume growth and $50-100M+ in initial subsidy/marketing.
Digital Asset Derivatives and Tokenization
Following the 2025 migration of digital futures to Cboe Futures Exchange, Cboe is targeting crypto-linked derivatives and tokenization-high-growth areas driven by rising institutional Bitcoin and Ether demand; institutional crypto holdings reached about $56 billion in 2024, up ~22% year-over-year.
Cboe's market share remains small versus native crypto venues-spot and derivatives volume on centralized crypto exchanges exceeded $2.4 trillion in 2024-so these assets sit as Question Marks in the BCG matrix.
To convert them into Stars, Cboe must invest tens to hundreds of millions in regulatory-compliant clearing, custody, and tokenization rails; without this, adoption and market share gains will lag native exchanges.
Cboe Australia and Cboe Canada (Pre-Sale)
Until their potential sale is finalized, Cboe Australia and Cboe Canada remain Question Marks in CBOE Global Markets' BCG matrix: both show growth but lack the dominant share of U.S./European units. In 2025 Australian equities volumes rose 28% year-over-year to about A$180 billion traded, yet Cboe moved to explore a sale to redeploy capital into core U.S. products. These units are high-potential assets likely worth more to buyers with regional focus.
Bitcoin-Linked ETF Options
The launch of options on spot Bitcoin ETFs is a high-growth chance in a nascent segment; as of Q4 2025 spot BTC ETFs held $87.3B AUM and options could capture double-digit annual trading growth, with market share still open.
Cboe is funding marketing and liquidity programs-$45M in 2024-25 spend and expanded maker rebates-to be the primary venue; success could move these listings to Stars quickly.
Current status: heavy R&D and regulatory capital drain-~$28M regulatory/legal costs YTD-and execution risk; upside: rapid fee revenue if options reach 5-10% of ETF volume.
- High growth: spot BTC ETFs $87.3B AUM (Q4 2025)
- Investment: $45M marketing/liquidity (2024-25)
- Costs: $28M regulatory/R&D YTD
- Upside: fee revenue if options = 5-10% ETF volume
Cboe Clear Europe Securities Financing Transactions (SFT)
Cboe Clear Europe Securities Financing Transactions (SFT) is a Question Mark: a 2025 launch into European securities lending with high growth potential but low current Cboe share; success needs broad adoption and network effects to reach profitability.
Market context: European SFT market ≈ €1.2 trillion outstanding (2024 ESMA data); Cboe's share near 0% at launch; similar clearing ramps show 3-5 years to scale and break-even.
- New venture into €1.2T European SFT market (ESMA 2024)
- Low initial Cboe share; needs industry-wide adoption
- Efficiency gains vs opaque/fragmented legacy market
- 3-5 years and sustained spend likely to achieve network effects
Cboe's $50-200M bet: Scale crypto, SFT & events to reach break – even in 3-5 years
Cboe's Question Marks (event markets, crypto derivatives, regional units, SFT) need $50-200M capex/marketing and 30-50% YoY volume growth to become Stars; current shares are near 0% vs $2.4T crypto (2024) and €1.2T SFT (2024), with $45M marketing and ~$28M regulatory spend (2024-25) so break – even likely 3-5 years under successful scale.
| Asset | Market Size (latest) | Cboe spend | Target |
|---|---|---|---|
| Event/prediction | $1.5-2.0B (2025) | $50-100M | 30-50% YoY growth |
| Crypto derivatives | $2.4T vol (2024) | $50-200M | 3-5 yrs to scale |
| Regional units | AUS A$180B vol (2025) | Undisclosed | Sale / redeploy capital |
| SFT clearing | €1.2T outstanding (2024) | $30-60M | 3-5 yrs to break – even |
Frequently Asked Questions
Yes, it is built specifically for CBOE Global Markets using a company-specific, research-driven analysis. That helps you avoid generic assumptions and quickly understand how its options, futures, equities, ETPs, FX, and volatility businesses fit into a BCG Matrix. It is designed for professional, presentation-ready use in investor decks or board discussions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.